- Published at
- by gurufocus.com
mixed
mixed
Notice of Nominees for Directors
PR NewswireTOKYO, May 7, 2025
TOKYO, May 7, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today annou
News for ImmunoGen, Inc. (IMU.DE)
- Published at
- by business-standard.com
mixedmixedJapanese firm Daiichi wants to go alone in search of targeted cancer drugs
AstraZeneca Plc and Daiichi's breast cancer drug Enhertu is based off of Daiichi's antibody-drug conjugate platform DXd, and was the top-selling ADC globally in 2023- Published at
- by globenewswire.com
neutralneutralAscendis to Present First Results from Platinum-Resistant Ovarian Cancer (PROC) Cohort of the Phase 1/2 IL-Believe Trial at ESMO 2024
Anti-tumor clinical responses were observed in 29% (4/14) of efficacy-evaluable patients with PROC treated with TransCon IL-2 β/γ in combination with...- Published at
- by globenewswire.com
mixedmixedAntibody Drug Conjugates Market Is Expected To Reach Revenue Of USD 51.2 Bn By 2033, at 15.8% CAGR: Dimension Market Research
Advancements and Projections in the Antibody Drug Conjugates Market: Insights, Trends, Opportunities, and Recent Developments...- Published at
- by globenewswire.com
mixedmixedIDH Inhibitor Market to Exhibit Significant Growth Rate During the Study Period (2020–2034) | DelveInsight
The IDH inhibitors market is expected to grow significantly in the coming years. This is due to the rising occurrence of IDH-mutated cancers, such as acute...- Published at
- by finance.yahoo.com
positivepositiveLee Ainslie's Strategic Moves in Q1 2024: A Deep Dive into Coupang Inc's Significant Reduction
Insights from Maverick Capital's Latest 13F Filing- Published at
- by gurufocus.com
positivepositiveLee Ainslie's Strategic Moves in Q1 2024: A Deep Dive into Coupang Inc's Significant Reduction
Insights from Maverick Capital's Latest 13F Filing Lee Ainslie (Trades, Portfolio), the founder and CEO of Maverick Capital, has once again made notable change- Published at
- by globenewswire.com
mixedmixedGlobal Ovarian Cancer Treatment Drugs Market Size To Exceed USD 5.45 Billion By 2033 | CAGR OF 8.10%
The Global Ovarian Cancer Treatment Drugs Market Size was Valued at USD 2.50 Billion in 2023 and the Worldwide Ovarian Cancer Treatment Drugs Market Size...- Published at
- by seekingalpha.com
mixedmixed3 Potential Biopharma Buyout Targets
Drug blockbusters facing key patent expirations and Big Pharma's surplus of cash suggest increased M&A volume in the coming year. Click here to read our picks.- Published at
- by seekingalpha.com
positivepositive3 Potential Biotech Buyout Targets In 2024
Biotech M&A activity surged at the end of 2023, which helped small biotech sector surge. Find out 3 logical buyout targets in biotech/biopharma space in 2024.- Published at
- by insidermonkey.com
positivepositiveMacroGenics, Inc. (NASDAQ:MGNX) Q4 2023 Earnings Call Transcript
Operator: Good afternoon. We will begin the MacroGenics 2023 Fourth Quarter Corporate Progress and Financial Results Conference Call in just a moment.- Published at
- by globenewswire.com
mixedmixedSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SRC, EAR, BVH, IMGN
NEW YORK, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...- Published at
- by marketscreener.com
positivepositiveALERT: The M&A Class Action Firm Continues Investigating the Merger - PATI, ROVR, SRC, IMGN -December 08, 2023 at 08:01 pm EST
NEW YORK, Dec. 8, 2023 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC , a national securities firm rated Top 50 in the 2018-2022...- Published at
- by benzinga.com
mixedmixedWhy Titan Machinery Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session - AgriFORCE Growing Systems (NASDAQ:AGRI), Aditxt (NASDAQ:ADTX)
Shares of Titan Machinery Inc. (NASDAQ: TITN) moved lower during Thursday’s trading following weak quarterly results.- Published at
- by benzinga.com
mixedmixedLa-Z-Boy Posts Upbeat Earnings, Joins Victoria's Secret, Snowflake And Other Big Stocks Moving Higher On Thursday - Compass Pathways (NASDAQ:CMPS), Bicycle Therapeutics (NASDAQ:BCYC)
U.S. stocks traded mostly higher, with the Dow Jones index gaining around 200 points on Thursday.- Published at
- by globenewswire.com
mixedmixedOvarian Cancer Drugs Market Size Worth USD 5.35 Billion in 2032 | Emergen Research
Technological advancements and development in cancer treatment, extensive Research & Development (R&D) in novel drug therapeutics, and increasing use of...- Published at
- by insidermonkey.com
mixedmixed12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
In this article we present the list of 12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds.- Published at
- by seekingalpha.com
mixedmixedI Got 99 Problems But A High Yield Ain't One (151 Trade Ideas)
Discover how our Advanced cash covered put selling strategy can help you generate high yields while minimizing market risk. Click for our exclusive picks.CMAC1MA34.SAALGT0I1P.LZS.MXZSW.MXWVRTVNX.DEUPWK.MXUPWKUPSTTXN.MXTXNTSLAD.BATSLAC.BATSLA34.SATSLA.MXTSLATL0.DETII.DETEXA34.SATDS-PVTDS-PUTDSSTRLSRXM34.SASOFI.MXSMCISIRISGRYTM.MXRYTMROKU.MXROKURDO.DEQCOM34.SAQCOM.SNQCOM.MXQCOM.BAQCOMQCI.DEPPQ.DEPPG.MXPPGP1PG34.SAOYC.DENSC.MXNSCNFS.DENETN1SC34.SAMX4A.DEMTZMPN.DEMPC.MXMPCMLIMGMM1PC34.SALPXLLY.MXLLY.DELLY.BALLYLILY34.SALII.MXLIILAZR.MXLAZRIRBTIMU.DEIMGNI8R.DEGMCO34.SAGM.MXGMGH.MXGHFMC1.DEFIVN.MXFIVNF.SWF.MXFERIEEOG.MXEOGE1OG34.SADTDEAI34.SADAL.MXDALCWHCOINCME.MXCHME34.SACELHBYND.MXBYNDBAX.MXBAXB2YN34.SAAVGOPAVGOD.BAAVGO34.SAAVGO.MXAVGO.BAAVGOAPC.DEAMGN.MXAMGN.BAAMGNAMG.DEAMBAAI1.MXAIAEOAAPLD.BAAAPLCL.SNAAPLC.BAAAPL.SNAAPL.NEAAPL.MXAAPL.BAAAPLAALL34.SAAAL.MXAALA1G.DE8GM.DE1YD.DE1QZ.DE1F9.DE0ZC.DE0YXG.L0YU1.L0XVU.L0TMV.L0R38.L0R2H.L0QZ4.L0QK8.L0Q3.DE0Q1G.L0L6Z.L0KXI.L0KEI.L0K8M.L0JYA.L0IDR.L0HSU.L0HR2.L0HE6.L0A4A.LMDB.MXMDBM1DB34.SABBIO0KKZ.L- Published at
- by prnewswire.com
mixedmixedThe Galien Foundation Announces 2023 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Product" and "Best Product for Rare
/PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today announced the 2023 Prix Galien...- Published at
- by globenewswire.com
mixedmixedAcute Myeloid Leukemia Market Size and Share to Rise by 2032, Predicts DelveInsight | Key Companies - Chimerix, GlycoMimetics, Arog, Delta-Fly, Jasper, Jazz, Daiichi Sankyo, Amgen, AbbVie, Merck, Eli
The acute myeloid leukemia market has a promising outlook with emerging therapies. The overall dynamics of the acute myeloid leukemia market are...